Salvadora persica (miswak) mouthrinse vs Chlorhexidine mouthrinse
Plaque · Medically healthy individuals (adults and children, 6-60 years)
When usual mechanical plaque control continued, Salvadora persica and chlorhexidine did not differ significantly for plaque; not GRADE-rated.
8 findings from 1 review
- The antiplaque/anticariogenic efficacy of Salvadora persica (Miswak) mouthrinse in comparison to that of… 2019 All outcomesPost-intervention · In vivo clinical trial (human oral cavity) · Did not refrain from mechanical plaque controlMD 0.17 [-0.08, 0.42]11 studies · 594 participantsGRADE not reported
- The antiplaque/anticariogenic efficacy of Salvadora persica (Miswak) mouthrinse in comparison to that of… 2019 All outcomesPost-intervention · In vivo clinical trial (human oral cavity) · Duration of mouthwash use: >=3 weeksMD 0.24 [-0.11, 0.60]7 studies · 420 participantsGRADE not reported
- The antiplaque/anticariogenic efficacy of Salvadora persica (Miswak) mouthrinse in comparison to that of… 2019 All outcomesPost-intervention · In vivo clinical trial (human oral cavity)MD 0.19 [0.01, 0.37]18 studies · 902 participantsGRADE not reported
Show 5 more findings
- The antiplaque/anticariogenic efficacy of Salvadora persica (Miswak) mouthrinse in comparison to that of… 2019 All outcomesPost-intervention · In vivo clinical trial (human oral cavity) · Refrained from mechanical plaque controlMD 0.22 [0.05, 0.39]7 studies · 308 participantsGRADE not reported
- The antiplaque/anticariogenic efficacy of Salvadora persica (Miswak) mouthrinse in comparison to that of… 2019 All outcomesPost-intervention · In vivo clinical trial (human oral cavity) · Study quality: moderate-quality studiesMD 0.19 [-0.11, 0.50]10 studies · 616 participantsGRADE not reported
- The antiplaque/anticariogenic efficacy of Salvadora persica (Miswak) mouthrinse in comparison to that of… 2019 All outcomesPost-intervention · In vivo clinical trial (human oral cavity) · Duration of mouthwash use: <3 weeksMD 0.15 [0.01, 0.29]11 studies · 482 participantsGRADE not reported
- The antiplaque/anticariogenic efficacy of Salvadora persica (Miswak) mouthrinse in comparison to that of… 2019 All outcomesPost-intervention · In vivo clinical trial (human oral cavity) · Chlorhexidine concentration: 0.12%MD 0.52 [0.35, 0.69]5 studies · 396 participantsGRADE not reported
- The antiplaque/anticariogenic efficacy of Salvadora persica (Miswak) mouthrinse in comparison to that of… 2019 All outcomesPost-intervention · In vivo clinical trial (human oral cavity) · Study quality: high-quality studiesMD 0.19 [0.06, 0.31]8 studies · 286 participantsGRADE not reported